{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:01:33Z","timestamp":1792659693527,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jmii.2021.12.007","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T01:12:42Z","timestamp":1642036362000},"page":"183-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["COVID-19 associated mucormycosis \u2013 An emerging threat"],"prefix":"10.1016","volume":"55","author":[{"given":"Chien-Ming","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-2388","authenticated-orcid":false,"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-800X","authenticated-orcid":false,"given":"Wen-Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2021.12.007_bib2","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2021.12.007_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jmii.2020.02.012","article-title":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths","volume":"53","author":"Lai","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.12.007_bib4","doi-asserted-by":"crossref","first-page":"106024","DOI":"10.1016\/j.ijantimicag.2020.106024","article-title":"Extra-respiratory manifestations of COVID-19","volume":"56","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2021.12.007_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","article-title":"Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents?","volume":"53","author":"Lai","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.12.007_bib6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jmii.2020.05.005","article-title":"First COVID-19 mortality case in Taiwan with bacterial co-infection by national surveillance of critically ill patients with influenza-negative pneumonia","volume":"53","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.12.007_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis","volume":"16","author":"Musuuza","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2021.12.007_bib8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/pathogens10070809","article-title":"Coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV-2: a systematic review and meta-analysis","volume":"10","author":"Alhumaid","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jmii.2021.12.007_bib9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2021.12.007_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","article-title":"COVID-19 associated with pulmonary aspergillosis: a literature review","volume":"54","author":"Lai","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.12.007_bib11","doi-asserted-by":"crossref","first-page":"2100510","DOI":"10.2807\/1560-7917.ES.2021.26.23.2100510","article-title":"Case series of four secondary mucormycosis infections in COVID-19 patients, The Netherlands, December 2020 to May 2021","volume":"26","author":"Buil","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jmii.2021.12.007_bib12","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicenter study from Iran","volume":"64","author":"Pakdel","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2021.12.007_bib13","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2021.12.007_bib14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/qjmed\/hcab166","article-title":"Mucormycosis- A dreaded complication of Covid-19","volume":"114","author":"Selarka","year":"2021","journal-title":"QJM"},{"key":"10.1016\/j.jmii.2021.12.007_bib15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/alr.22785","article-title":"Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19)","volume":"11","author":"Karimi-Galougahi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jmii.2021.12.007_bib16","doi-asserted-by":"crossref","first-page":"101125","DOI":"10.1016\/j.mycmed.2021.101125","article-title":"Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - case report and review of literature","volume":"31","author":"Khatri","year":"2021","journal-title":"J Mycol Med"},{"key":"10.1016\/j.jmii.2021.12.007_bib17","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/IOP.0000000000001889","article-title":"Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome","volume":"37","author":"Mekonnen","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jmii.2021.12.007_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11046-020-00451-y","article-title":"First case of rhinocerebral mucormycosis caused by Lichtheimia ornata, with a review of Lichtheimia Infections","volume":"185","author":"Pan","year":"2020","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jmii.2021.12.007_bib19","first-page":"435","article-title":"Mucormycosis","volume":"35","author":"Steinbrink","year":"2021","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.jmii.2021.12.007_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s15010-018-1138-0","article-title":"Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts","volume":"46","author":"Ajmal","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.jmii.2021.12.007_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.transproceed.2018.12.023","article-title":"Severe gastric mycormycosis infection followed by cytomegalovirus pneumonia in a renal transplant recipient: a case report and concise review of the literature","volume":"51","author":"Peng","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jmii.2021.12.007_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005054","article-title":"Fatal systemic adenoviral infection superimposed on pulmonary mucormycosis in a child with acute leukemia: a case report","volume":"95","author":"Seo","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jmii.2021.12.007_bib23","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S2666-5247(20)30115-4","article-title":"Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study","volume":"1","author":"Hanley","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jmii.2021.12.007_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: a case report","volume":"53","author":"Monte Junior","year":"2020","journal-title":"Clin Endosc"},{"key":"10.1016\/j.jmii.2021.12.007_bib25","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.radcr.2020.09.026","article-title":"Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia","volume":"15","author":"Placik","year":"2020","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.jmii.2021.12.007_bib26","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jmii.2021.12.007_bib27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis","volume":"49","author":"Pasero","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.jmii.2021.12.007_bib28","doi-asserted-by":"crossref","first-page":"645270","DOI":"10.3389\/fmed.2021.645270","article-title":"Spike in rhino-orbital-cerebral mucormycosis cases presenting to a tertiary care center during the COVID-19 pandemic","volume":"8","author":"Fouad","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jmii.2021.12.007_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neurad.2021.05.007","article-title":"Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: a case series and a review of literature","volume":"48","author":"Ashour","year":"2021","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.jmii.2021.12.007_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10384-021-00845-5","article-title":"Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations","volume":"65","author":"Bayram","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jmii.2021.12.007_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13652","article-title":"Mucormycosis associated with COVID-19 in two kidney transplant patients","volume":"23","author":"Arana","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jmii.2021.12.007_bib32","article-title":"Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: a case report","author":"Veisi","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jmii.2021.12.007_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/jof7020088","article-title":"Autopsy proven pulmonary mucormycosis due to Rhizopus microsporus in a critically ill COVID-19 patient with underlying hematological malignancy","volume":"7","author":"Zurl","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2021.12.007_bib34","doi-asserted-by":"crossref","first-page":"264.e265","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jmii.2021.12.007_bib35","article-title":"A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19","volume":"13","author":"Waizel-Haiat","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jmii.2021.12.007_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"Alekseyev","year":"2021","journal-title":"J Med Cases"},{"key":"10.1016\/j.jmii.2021.12.007_bib37","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?","volume":"9","author":"Raut","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jmii.2021.12.007_bib38","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2,826 patients in India - collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jmii.2021.12.007_bib39","doi-asserted-by":"crossref","first-page":"103080","DOI":"10.1016\/j.amjoto.2021.103080","article-title":"The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis","volume":"42","author":"Ismaiel","year":"2021","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jmii.2021.12.007_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jmii.2021.12.007_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, Uncontrolled diabetes and corticosteroids-An unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"key":"10.1016\/j.jmii.2021.12.007_bib42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4103\/ijo.IJO_1053_21","article-title":"Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: clinico-radiological features","volume":"69","author":"Rao","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jmii.2021.12.007_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jmii.2021.12.007_bib44","first-page":"1","article-title":"Maxillofacial infections in Covid-19 era-actuality or the unforeseen: 2 Case reports","author":"Sai Krishna","year":"2021","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jmii.2021.12.007_bib45","first-page":"1","article-title":"Paranasal mucormycosis in COVID-19 patient","author":"Saldanha","year":"2021","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jmii.2021.12.007_bib46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jmii.2021.12.007_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13663","article-title":"Mucormycosis in post-COVID-19 renal transplant patients: a lethal complication in follow-up","volume":"23","author":"Meshram","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jmii.2021.12.007_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijmmb.2021.05.009","article-title":"Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: case series from the north-western part of India","volume":"39","author":"Nehara","year":"2021","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jmii.2021.12.007_bib49","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: mucormycosis in COVID-19 times","volume":"69","author":"Ravani","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jmii.2021.12.007_bib50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jmii.2021.12.007_bib51","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2214\/AJR.21.26205","article-title":"CT and MRI findings of invasive mucormycosis in the setting of COVID-19: experience from a single center in India","volume":"217","author":"Joshi","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jmii.2021.12.007_bib52","doi-asserted-by":"crossref","first-page":"105957","DOI":"10.1016\/j.ijscr.2021.105957","article-title":"Sino-orbital mucormycosis in a COVID-19 patient: a case report","volume":"82","author":"Maini","year":"2021","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.jmii.2021.12.007_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land: a tale of two pathogens","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"Suppl 3","key":"10.1016\/j.jmii.2021.12.007_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/myc.12243","article-title":"Mucormycosis in India: unique features","volume":"57","author":"Chakrabarti","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2021.12.007_bib55","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.jmii.2021.12.007_bib56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2958.2010.07234.x","article-title":"The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis","volume":"77","author":"Ibrahim","year":"2010","journal-title":"Mol Microbiol"},{"issue":"Suppl 3","key":"10.1016\/j.jmii.2021.12.007_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/myc.12232","article-title":"Host-iron assimilation: pathogenesis and novel therapies of mucormycosis","volume":"57","author":"Ibrahim","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2021.12.007_bib58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmii.2021.12.007_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01087-20","article-title":"GRP78 and integrins play different roles in host cell invasion during mucormycosis","volume":"11","author":"Alqarihi","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jmii.2021.12.007_bib60","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jiph.2021.09.004","article-title":"COVID19 associated mucormycosis: is GRP78 a possible link?","volume":"14","author":"Gumashta","year":"2021","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jmii.2021.12.007_bib61","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI82744","article-title":"Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis","volume":"126","author":"Gebremariam","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmii.2021.12.007_bib62","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jmii.2021.12.007_bib63","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2021.12.007_bib64","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/myc.13256","article-title":"The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis","volume":"64","author":"Ahmadikia","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2021.12.007_bib65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2021.12.007_bib66","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/mmy\/myw014","article-title":"The environmental source of emerging Apophysomyces variabilis infection in India","volume":"54","author":"Prakash","year":"2016","journal-title":"Med Mycol"},{"issue":"Suppl 5","key":"10.1016\/j.jmii.2021.12.007_bib67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2009.02972.x","article-title":"The ecology of the Zygomycetes and its impact on environmental exposure","volume":"15","author":"Richardson","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2021.12.007_bib68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/jof7030174","article-title":"A fatal case of Rhizopus azygosporus pneumonia following COVID-19","volume":"7","author":"Kanwar","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2021.12.007_bib69","first-page":"1","article-title":"Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19","author":"Dallalzadeh","year":"2021","journal-title":"Orbit"},{"key":"10.1016\/j.jmii.2021.12.007_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01172","article-title":"Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection","volume":"25","author":"Krishna","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.jmii.2021.12.007_bib71","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.12.007_bib72","first-page":"633","article-title":"Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient","volume":"51","author":"Bellanger","year":"2021","journal-title":"Infect Dis News"},{"key":"10.1016\/j.jmii.2021.12.007_bib73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mmcr.2021.03.006","article-title":"Pulmonary aspergillosis and mucormycosis in a patient with COVID-19","volume":"32","author":"Johnson","year":"2021","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.jmii.2021.12.007_bib74","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2021.12.007_bib75","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2021.12.007_bib76","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/13543776.2021.1939308","article-title":"Mucormycosis medications: a patent review","volume":"31","author":"Imran","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jmii.2021.12.007_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mmcr.2021.03.005","article-title":"Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement","volume":"32","author":"Miller","year":"2021","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.jmii.2021.12.007_bib78","first-page":"e2547","article-title":"Isavuconazole: a promising salvage therapy for invasive mucormycosis","volume":"10","author":"Shafiq","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.jmii.2021.12.007_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00591","article-title":"Rhinoorbital mucormycosis in the immunocompetent: experience with isavuconazole","volume":"18","author":"Ilharco","year":"2019","journal-title":"IDCases"},{"key":"10.1016\/j.jmii.2021.12.007_bib80","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/INF.0000000000002671","article-title":"Isavuconazole as successful salvage therapy for mucormycosis in pediatric patients","volume":"39","author":"Ashkenazi-Hoffnung","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2021.12.007_bib81","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1128\/AAC.01919-15","article-title":"In\u00a0vitro activity of isavuconazole and comparators against clinical isolates of the Mucorales order","volume":"59","author":"Arendrup","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2021.12.007_bib82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/jof6040324","article-title":"Isavuconazole: mechanism of action, clinical efficacy, and resistance","volume":"6","author":"Ellsworth","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2021.12.007_bib83","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code Mucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:27:34Z","timestamp":1761658054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1684118222000019"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2021.12.007","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 associated mucormycosis \u2013 An emerging threat","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2021.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}